HBV management: Guidance for PCPs
This updated 2025 guidance offers practical recommendations for the prevention, diagnosis, and management of hepatitis B—aimed specifically for primary care providers and non-specialists. Developed by the HBV Primary Care Workgroup, it builds on the original 2020 guidance with simplified, up-to-date information to support clinical decision-making.
introduction to updated Hbv guidelines 2025
The Canadian Association for the Study of the Liver (CASL) and the Association of Medical Microbiology and Infectious Disease Canada (AMMI) have released new guidelines for the management of chronic hepatitis B. Watch this educational webinar, with speakers from the Canadian Hepatitis B Network, to learn more.
Hepatitis Delta Coinfection
The Hepatitis B Foundation interviewed Dr. Coffin about Hepatitis Delta Coinfection -- the challenges and the opportunities ahead.
HOW IS HEPATITIS DELTA TREATED?
In this video, Helenie Kefalakes, specialist in internal medicine at the Department for Gastroenterology, Hepatology, Infectiology and Endocrinology at the Hannover Medical School in Germany, answers the following questions in her lecture “Standard of treatment in Germany and worldwide”
• How should hepatitis D virus infection be treated?
• How can patients with advanced liver disease be treated?
• When is a liver transplant an option?
Canadian viral hepatitis elimination day
The Canadian Hepatitis B Network, The Canadian Hepatitis C Network, the Canadian Liver Foundation, and Action Hepatitis Canada joined forces in Ottawa on May 9, 2024 to present five asks to the federal government to bring urgency to eliminating hepatitis by 2030.
More highlights from this event can be found here: